Dovitinib

Dovitinib is a potent growth factor receptor kinase inhibitor with effects against FLT-3, c-KIT, VEGFR, PDGFRß and CSF-1R.

405169-16-6

4-​​amino-​​5-​​fluoro-​​3-​​[6-​​ (4-​​methyl-​​1-​​piperazinyl) ​-​​1H-​​benzimidazol-​​2-​​yl]​-​2 (1H) ​-​​quinolinone

41116105

Inhibitor

Synthetic

Cell Signaling

≥98%

0.025

Crystalline solid

Soluble in DMSO

C21H21FN6O

392.4

Not for use in humans. Not for use in diagnostics or therapeutics. For in vitro research use only.

1. Konecny G.E., et al. (2013) Mol. Cancer Ther. 12(5): 632–642.